Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.84 USD | +0.57% | +8.87% | -10.34% |
04-18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
04-16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.34% | 2.1B | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Berenberg Bank Trims Recursion Pharmaceuticals' Price Target to $36 From $37 on Delayed REC-3599 Timeline; Buy Rating Kept